A transcript of the video narration is below:
This is Nathan Radcliffe, MD, chief medical editor of Glaucoma Physician. I’m here at the American Glaucoma Society’s 2025 meeting in Washington, DC. Some of the data that is being presented here is on the negative-pressure goggles [the FSYX Ocular Pressure Adjusting Pump; Balance Ophthalmics], which can reduce the intraocular pressure (IOP) through a vacuum pump using goggles that have a tight fitting seal around the eyes. Now, if you think about this technology, it is the only nonmedical, nonsurgical, nonlaser way of lowering the intraocular pressure. It has FDA clearance and it is now available for our patients.
One of the amazing things, as we look at all the data, is that every patient responds to this therapy. This is amazing because we all know about nonresponders with prostaglandin analogs, the most common medication class. Every class of medicine, and even every type of surgery or laser, has some nonresponders. But in all the clinical data with the Balance goggles, everybody has responded. Additionally, it’s titratable, so we get to determine how much intraocular pressure reduction we want to achieve. We do this by dialing in how much negative pressure to apply, and we get a certain amount of pressure reduction in return. You can adjust this over time, and you can be dynamic if a patient has to stop a medicine. You can change the settings if they add a medicine; you don't need as much suction, you can make those settings as well.
I've had the experience of using these goggles on some of my patients, and the patients are thrilled. A lot of our glaucoma patients are really worried about their disease. They’re looking for some way of controlling it, and this offers them quite a fantastic new approach. I look forward to seeing how this product is used by my colleagues, and learning more from them, but I am excited because my initial experience, as well as the data that’s been produced, has all been fantastic. GP
